Why prevention with vitamins is so important:

In Sweden the situation is so serious that citizens can no longer afford to buy medicines cash, because those are too expensive and people are forced to buy medicine in pay offs, although they are members of the sick fund.

A nourishment science team at the Schwarzwald sanatorium Obertal (Germany) has made a comparison between 1985 and 1996 between two equally identical groceries baskets with broccoli, bean, fennel, carrots, potatoes, spinach, apples, bananas and strawberries. A laboratory in Karlsruhe (Germany) examined the beforementioned items and what do you think was the result?

In broccoli the lack of calcium was ­ 68%, folic acid - 52%, magnesium - 35%.
In spinach, Magnesium - 68%, - 59% vitamin B6, - 58% vitamin C.
In bananas, the calcium sank by - 12%, folic acid - 84%, magnesium -13%,
vitamin B6 - 92%.

In strawberries 14% less calcium, 67% less vitamin C and magnesium increased with + 8%.

Apples lost 80% at vitamin C and have an increase of calcium of 12% and magensium of 20%.

These alarming figures talk for themselves ­ there is only one solution: Vitamins & Co preferable in liquid form, because the body absorbs this much quicker and better than tablets.

Daily water intake is extremely important because if our body does not get enough water it is like a car radiator start boiling. The result could be that your kidneys will get a collic.

Too little movement - makes the body sour. To avoid this problem, make daily a promenade of 45 minutes instead of using the car!

Which roll plays the intestine?

The roots of our health lie in intestine; indigestion can lead to serious damages in the total organism. In the intestine, millions of microorganisms live altogether, each one a friendly representative of its group which takes care of a part of the digestion.

The intestine as a most frequent cause.

Often the original interference lies in intestine. Intestine interferences appear in very different trouble pictures:

Wind, clogging, diarrhea, hert-burn, vomiting, hiccup, intestine inflammations, piles, wound in the intestine exit, symptom of the self poisoning as well as chronic fatigue, headache, shooting pains or repeated infections.

Aid to the diagnosis.
For the untrained, it is very difficult to recognize a chronical over-acidity based on physical symptoms. By means of the following list, I hope the below hints will make it
easier for you to get a picture of your metabolism situation.

Gout, allergy, arteriosclerosis, diabetes mellitus, connective tissue disease, osteoporosis, migraine, rheumatism, neurodermitis, heart attack, cancer diseases, gall- or kidney stones, stomach ­ intestine ­ abscesses, pain syndrome.

These troubles are brought with chronic over-acidity in the connection.
_ weakened immune system, permanent flue or continuous infection. _ nails brittle or permanent nail fungus _ hairs brittle _ dull and blunt _or hair loss_ pale complexion _ chronic skin inflammation or skin pus_ chronic skin itch _ skin disease. _ caries, chronic gums blood or paradonitis. _indigestion with intestine inertia or chronical intestine irritation with winds _sour burps _ stomach mucous membrane irritation _ yeast fungus diseases in the mouth or stomach-intestine area _ feet permanently cold _ and/or hands and/or migraine _ muscle hardening or tension, above all in the neck area , shoulders and back muscles _ a very burdened nerve system, easy irritability and chronical fatigue _ high pain sensitivity in the skin or in the body _ chronical pain, condition for which also after intensive diagnostic action no cause can be found.

How does one repair already appeared damages?
Change meal habits, positive thinking, every day (much walking and daily 2,5 ­3 liters of fluid drink) as well as multi­vitamin preparation (vitamins, minerals, trace elements and amino acids) in fluid form (kollodial).

I wish you good luck!

See this table with the results for a pharmaceutical company called Geigy - a pharmaceutical industry in Switzerland:

The way of using more vitamins, minerals and aminoacids to stay healthy is called cellular medicine.

References.

The following comprehensive lits of references is compiled to document the broad support nutrional and Cellular Medicine already has. You will find theses publications in larger public libraries and in the library of any medical school.

Armstrong VW, Cremer P, Eberle E, et al. (1986) The association
between serum Lp(a) concentrations and angiographically
assessed coronary atherosclerosis. Dependence on
serum LDL levels. Atherosclerosis 62: 249-257.

Altschul R, Hoffer A, Stephen JD. (1955) Influence of nicotinic
acid on serum cholesterol in man. Archives of Biochemistry
and Biophysics 54: 558-559.

Aulinskas TH, Van Westhuyzen DR, Coetzee GA. (1983)
Ascorbate increases the number of low density lipoprotein
receptors in cultured arterial smooth muscle cells. Atherosclerosis
47: 159-171.

Avogaro P, Bon G B, Fusello M. (1983) Effect of pantethine on
lipids, lipoproteins and apolipoproteins in man. Current
Therapeutic Research 33: 488-493.

Bates CJ, Mandal AR, Cole TJ. (1977) HDL. cholesterol and
vitamin-C status. The Lancet II: 611.
Beamish R. (1993) Vitamin E - then and now. Canadian Journal
of Cardiology 9: 29-31.

Beisiegel U, Niendorf A, Wolf K, Reblin T, Rath M. (1990)
Lipoprotein(a) in the arterial wall. European Heart Journal
11 (Supplement E): 174-183.

Bendich A. (1992) In Beyond Deficiency - New views on the
function and health effects of vitamins. Annals of the New
York Academy of Sciences 669: 300-312.

Berg K. (1963) A new serum type system in man - the Lp
system. Acta Pathologica Scandinavia 59: 369-382.
Blumberg A, Hanck A, Sandner G. (1983) Vitamin nutrition in
patients on continuous ambulatory peritoneal dialysis
(CAPD). Clinical Nephrology 20: 244-250.

Braunwald E, Hrsg. (1992) Heart Disease - A textbook of cardiovascular
medicine. W.B. Saunders & Company, Philadelphia.
Briggs M, Briggs M. (1972) Vitamin C requirements and oral
contraceptives. Nature 238: 277.

Carlson LA, Hamsten A, Asplund A. (1989). Pronounced lowering
of serum levels of lipoprotein Lp(a) in hyperlipidemic
subjects treated with nicotinic acid. Journal of Internal
Medicine (England) 226: 271-276.

Cherchi A, Lai C, Angelino F, Trucco G, Caponnetto S, Mereto
PE, Rosolen G, Manzoli U, Schiavoni G, Reale A, Romeo F,
Rizzon P, Sorgente I, Strano A, Novo S, Immordino R.
(1985) International Journal of Clinical Pharmacology,
Therapy and Toxicology: 569-572.

Chow CK,Changchit C, Bridges RB, Rehn SR, Humble J, Turbek
J. (1986) Lower levels of vitamin C and carotenes in
plasma of cigarette smokers. Journal of the American College
of Nutrition 5: 305-312.

Clemetson CAB. (1989) Vitamin C, Volume I-III. CRC Press
Inc., Florida.

Cushing GL, Gaubatz JW, Nave ML, Burdick BJ, Bocan TMA,
Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett
JD. (1989) Quantitation and localization of lipoprotein(
a) and B in coronary artery bypass vein grafts resected
at re-operation. Arteriosclerosis 9: 593-603.

Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto
AM, Jr. (1986) Association of levels of lipoprotein LP(a),
plasma lipids, and other lipoproteins with coronary artery
disease documented by angiography. Circulation 74: 758-
765.

DeMaio SJ, King SB, Lembo NJ, Roubin GS, Hearn JA, Bhagavan
HN, Sgoutas DS. (1992) Vitamin E supplementation,
plasma lipids and incidence of restenosis after percutaneous
transluminal coronary angioplasty (PTCA). Journal of
the American College of Nutrition 11: 68-73.

Dice JF, Daniel CW. (1973) The hypoglycemic effect of ascorbic
acid in a juvenile-onset diabetic. International Research
Communications System: 1: 41.

Digiesi V. (1992) Mechanism of action of coenzyme Q10 in
essential hypertension. Current Therapeutic Research 51:
668-672.

England M. (1992) Magnesium administration and dysrhythmias
after cardiac surgery: A placebo-controlled, double-blind
randomized trial. Journal of the American Medical
Association 268: 2395-2402.

Enstrom JE, Kanim LE, Klein MA. (1992) Vitamin C intake and
mortality among a sample of the United States population.
Epidemiology 3: 194-202.

Ferrari R, Cucchini, und Visioli O. (1984) The metabolical
effects of L-carnitine in angina pectoris. International Journal
of Cardiology 5: 213-216.

Folkers K, Yamamura Y (Hrsg.). (1976, 1979, 1981,1984,
1986) Biomedical and clinical aspects of coenzyme Q.
Volume 1-5. Elsevier Science Publishers, New York.
Folkers K, Vadhanavikit S, Mortensen SA. (1985) Biochemical
rationale and myocardial tissue data on the effective
therapy of cardiomyopathy with coenzyme Q10. Procee-dings
of the National Academy of Sciences USA 82: 901-
904.

Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ, Ye CQ,
Tamagawa H. (1990) Lovastatin decreases coenzyme Q-10
levels in humans. Proceedings of the National Academy of
Sciences USA 87: 8931-8934.

Gaby SK, Bendich A, Singh VN, Machlin LJ (Hrsg.). (1991)
Vitamin intake and health. Marcel Dekker Inc. N.Y.

Gaddi A, Descovich GC, Noseda G, Fragiacomo C, Colombo
L, Craveri A, Montanari G, Sirtori CR. (1984) Controlled
evaluation of pantethine, a natural hypolipidemic compound,
in patients with different forms of hyperlipoproteinemia.
Atherosclerosis 5: 73-83.

Galeone F, Scalabrino A, Giuntoli F, Birindelli A, Panigada G,
Rossi, Saba P. (1983) The lipid-lowering effect of pantethine
in hyperlipidemic patients: a clinical investigation.
Current Therapeutic Research 34: 383-390.

Genest J Jr., Jenner JL, McNamara JR, Ordovas JM, Silberman
SR, Wilson PWF, Schaefer EJ. ( 1991) Prevalence of lipo-protein(
a) Lp(a) excess in coronary artery disease. American
Journal of Cardiology 67: 1039-1045.

Gerster H. (1991) Potential role of beta-carotene in the prevention
of cardiovascular disease. International Journal of Vita-min
and Nutrition Research 61: 277-291.

Gey KF, St=E4helin HB, Puska P und Evans A. (1987) Relationship
of plasma level of vitamin C to mortality from ischemic
heart disease.110-123. In: Burns JJ, Rivers JM, Machlin LJ
(Hrsg.): Third conference on vitamin C. Annals of the New
York Academy of Sciences 498.

Gey KF, Puska P, Jordan P, Moser UK. (1991) Inverse correlation
between plasma vitamin E and mortality from ischemic

heart disease in cross-cultural epidemiology. American
Journal of Clinical Nutrition 53: 326, Supplement.

Ghidini O, Azzurro M, Vita A, Sartori G. (1988) Evaluation of
the therapeutic efficacy of L-carnitine in congestive heart
failure. International Journal of Clinical Pharmacology,
Therapy and Toxicology 26: 217-220.

Ginter E. (1973) Cholesterol: Vitamin C controls its transformation
into bile acids. Science 179: 702.

Ginter E. (1978) Marginal vitamin C deficiency, lipid metabolism,

and atherosclerosis. Lipid Research 16: 216-220.
Ginter E (1991) Vitamin C deficiency cholesterol metabolism
and atherosclerosis. Journal of Orthomolecular Medicine 6:
166-173.

Guraker A, Hoeg JM, Kostner G, Papadopoulos NM, Brewer
HB Jr. (1985) Levels of lipoprotein Lp(a) decline with
neomycin and niacin treatment. Atherosclerosis 57: 293-
301.

Halliwell B, Gutteridge JMC (Hrsg.). (1985) Free radicals in
biology and medicine. Oxford University Press, London,
New York, Toronto.

Harwood HJ Jr, Greene YJ, Stacpoole PW (1986) Inhibition of
human leucocyte 3-hydroxy-3-methylglutaryl coenzyme A
reductase activity by ascorbic acid. An effect mediated by
the free radical monodehydro-ascorbate. Journal of Biological
Chemistry 261: 7127-7135.

Hearn JA, Donohue BC, Ba'albaki H, Douglas JS, King SBIII,
Lembo NJ, Roubin JS, Sgoutas DS. (1992) Usefulness of
serum lipoprotein(a) as a predictor of restenosis after percutaneous
transluminal coronary angioplasty. The American
Journal of Cardiology 68: 736-739.

Hermann WJ JR, Ward K, Faucett J. (1979) The effect of tocopherol
on high-density lipoprotein cholesterol. American
Journal of Clinical Pathology 72: 848-852.

Hemil=E4 H. (1992) Vitamin C and plasma cholesterol. In: Critical
Reviews in Food Science and Nutrition 32 (1): 33-57,
CRC Press Inc., Florida.

Hoff HF, Beck GJ, Skibinski CI, J=FCrgens G, O'Neil J, Kramer J,
Lytle B. (1988) Serum Lp(a) level as a predictor of vein graft
stenosis after coronary artery bypass surgery in patients.
Circulation 77: 1238-1244.

Iseri LT. (1986) Magnesium and cardiac arrhythmias. Magnesium
5: 111-126.

Iseri LT, French JH. (1984) Magnesium: nature's physiologic
calcium blocker. American Heart Journal 108: 188-193.

Jacques PF, Hartz SC, McGandy RB, Jacob RA, Russell RM.
(1987) Ascorbic acid, HDL, and total plasma cholesterol in
the elderly. Journal of the American College of Nutrition 6:
169-174.

Kamikawa T, Kobayashi A, Emaciate T, Hayashi H, Yamazaki
N. (1985) Effects of coenzyme Q-10 on exercise tolerance
in chronic stable angina pectoris. American Journal of Cardiology
56: 247-251

Koh ET. (1984) Effect of Vitamin C on blood parameters of
hypertensive subjects. Oklahoma State Medical Association
Journal 77: 177-182.

Korbut R. (1993) Effect of L-arginine on plasminogen-activator
inhibitor in hypertensive patients with hyper-cholesterolemia.
New England Journal of Medicine 328
[4]:287-288.

Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G,
Qunici GB. (1981) Lipoprotein Lp(a) and the risk for myocardial
infarction. Atherosclerosis 38: 51-61.

Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen
P. (1988) Effective and safe therapy with coenzyme
Q10 for cardiomyopathy. Klinische Wochenschrift 66:
583-590.

Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen
P. (1990) Pronounced increase of survival of patients
with cardiomyopathy when treated with coenzyme Q10
and conventional therapy. International Journal of Tissue
Reactions XIII (3) 163-168.

Lavie CJ. (1992) Marked benefit with sustained-release niacin
(vitamin B3) therapy in patients with isolated very low
levels of high-density lipoprotein cholesterol and coronary
artery disease. The American Journal of Cardiology 69:
1093-1085.

Lawn RM. (1992) Lipoprotein(a) in heart disease. Scientific
American. June: 54-60.

Lehr, HA, Frei B, Arfors KE. (1994) Vitamin C prevents cigarette
smoke-induced leucocyte aggregation and adhesion to
endothelium in vivo. Proceedings of the National Academy
of Sciences 91: 7688-7692.

Levine M. et al. (1996) Vitamin C pharmacokinetics in healthy
volunteers: Evidence for a recommended daily allowance.
Proceedings of the National Academy of Sciences 93:
3704-3709.

Liu VJ, Abernathy RP. (1982) Chromium and insulin in young
subjects with normal glucose tolerance. American Journal
of Clinical Nutrition 25: 661-667.

Mann GV, Newton P. (1975) The membrane transport of
ascorbic acid. Second Conference on Vitamin C. 243-252.
Annals of the New York Academy of Sciences.

Mather HM et al. (1979) Hypomagnesemia in diabetes. Clinical
and Chemical Acta 95: 235-242.

McBride PE und Davis JE. (1992) Cholesterol and cost-effectiveness
implications for practice, policy, and research.
Circulation 85: 1939-1941.

McCarron DA, Morris CD, Henry HJ und Stanton JL. (1984)
Blood pressure and nutrient intake in the United States.
Science 224: 1392-1398.

McNair P et al. (1978) Hypomagnesemia, a risk factor in diabetic
retinopathy. Diabetes 27: 1075-1077.

McSheehy PMJ und Chambers TJ. (1987) 1,25-Dihydroxyvitamin
D3 stimulates rat osteoblastic cells to release
a soluble factor that increases osteoclastic bone resorption.
Journal of Clinical Investigation 80: 425-429.

Miccoli R, Marchetti P, Sampietro T, Benzi L, Tognarelli M,
Navalesi R. (1984) Effects of pantethine on lipids and apolipoproteins
in hypercholesterolemic diabetic and nondia-betic
patients. Current Therapeutic Research 36: 545-549.

Mikami H et al. (1990) Blood pressure response to dietary calcium
intervention in humans. American Journal of Hypertension
3: 147-151.

Newman T, Hulley S. (1996) Cancerogenicity of Lipid-Lowering
Drugs. Journal of the American Medical Association
275 (1996) 55-60.

Niedzwiecki A, Ivanov V. (1994) Direct and extracellular
matrix mediated effect of ascorbate on vascular smooth
muscle cell proliferation. 24th AAA (Age) and 9th American
College of Clinical Gerontology Meeting Washington D.C.
Niendorf A, Rath M, Wolf K, Peters S, Arps H, Beisiegel U,
Dietel M. (1990) Morphological detection and quantifica-tion
of lipoprotein(a) deposition in atheromatous lesions of
human aorta and coronary arteries. Virchow's Archives of
Pathological Anatomy 417: 105-111.

Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB,
King SB, Berk BC. (1995) Combination of Vitamin C and
alters the response to coronary balloon injury in the pig.
Arteriosclerosis, Thrombosis and Vascular Biology 15: 156-
165.

Opie LH. (1979) Review: Role of carnitine in fatty acid metabolism
of normal and ischemic myocardium. American
Heart Journal 97: 375-388.

Paolisso G et al. (1993) Pharmacologic doses of vitamin
improve insulin action in healthy subjects and in non-insulin-
dependent diabetic patients. American Journal of Clinical
Nutriion 57: 650-656.

Paterson JC (1941): Canadian Medical Association Journal 44:
114-120.

Pauling L. (1986): Das Vitamin-Programm. Topfit bis ins hohe
Alter. Goldmann Verlag M=FCnchen.

Pfleger R, Scholl F. (1937) Diabetes und vitamin C. Wiener
Archiv f=FCr Innere Medizin 31: 219-230.

Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel
U. (1989) Detection and quantification of lipoprotein(a) in
the arterial wall of 107 coronary bypass patients. Arteriosclerosis
9: 579-592.

Rath M, Pauling L. (1990a) Hypothesis: Lipoprotein(a) is a surrogate
for ascorbate. Proceedings of the National Academy
of Sciences USA 87: 6204-6207.

Rath M, Pauling L. (1990b) Immunological evidence for the
accumulation of lipoprotein(a) in the atherosclerotic lesion
of the hypoascorbemic guinea pig. Proceedings of the
National Academy of Sciences USA 87: 9388-9390.

Rath M, Pauling L. (1991a) Solution to the puzzle of human
cardiovascular disease: Its primary cause is ascorbate deficiency,
leading to the deposition of lipoprotein(a) and fibrinogen/
fibrin in the vascular wall. Journal of Orthomolecular
Medicine 6: 125-134.

Rath M, Pauling L. (1991b) Apoprotein(a) is an adhesive protein.
Journal of Orthomolecular Medicine 6: 139-143.

Rath M, Pauling L. (1992a) A unified theory of human cardiovascular
disease leading the way to the abolition of this
disease as a cause for human mortality. Journal of Orthomolecular
Medicine 7: 5-15.

Rath M, Pauling L. (1992b) Plasmin-induced proteolysis and
the role of apoprotein(a), lysine, and synthetic lysine analogs.
Journal of Orthomolecular Medicine 7: 17-23.

Rath M. (1992c) Lipoprotein-a reduction by ascorbate. Journal
of Orthomolecular Medicine 7: 81-82.

Rath M. (1992d) Solution to the puzzle of human evolution.
Journal of Orthomolecular Medicine 7: 73-80.

Rath M. (1992e) Reducing the risk for cardiovascular disease
with nutritional supplements. Journal of Orthomolecular
Medicine 7: 153-162.

Rath M. (1993a) Cationic-anionic and anionic-cationic oligopeptides
in apoprotein(a) and other proteins as modulators
of protein action and of biological communication. Journal
of Applied Nutrition 44: 62-69.

Rath M. (1993b) Eradicating heart disease. Health Now Inc.,
San Francisco, USA.

Rath M. (1993c) A new era in medicine. Journal of Orthomolecular
Medicine 8: 134-135.

Rath M, Pauling L. (1993d): Die Entstehung von Herz-Kreislauf-
Erkrankungen. Vitamin-C-Mangel als Ursache f=FCr die
Ablagerung von Lipoprotein(a) und Fibrinogen/Fibrin in der
Gef=E4=DFwand. Journal f=FCr Orthomolekulare Medizin 1, Heft
2: 19-29.

Rath M. (1994a) Discovery of new elements of biological communication
leading the way to the abolition of infectious
diseases, cancer, and other diseases as causes of human
mortality. Journal of Orthomolecular Medicine 8: 11-20.
Rath M. (1994b) The Protein Code and principles of Peptide
Interception Therapy. Journal of Applied Nutrition 46: 32-
34.

Rath M. (1994c) Why animals don't get heart attacks. Health
Now Inc., San Francisco, USA.

Rath M. (1995) America's Most Successful Cardiovascular
Health Program. Health Now Inc., San Francisco, USA.

Rath M. und Niedzwiecki A. (1996) Nutritional Supplement
Program Halts Progression of Early Coronary Atherosclerosis
Documented by Ultrafast Computed Tomography.
Journal of Applied Nutrition 48.

Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL.
(1986) Lp(a) Lipoprotein as a risk factor for myocardial infarction.
Journal of the American Medical Association 256:
2540-2544.

Riales RR, Albrink MJ. Effect of chromium chloride supplementation
on glucose tolerance and serum lipids including
high-density lipoprotein of adult men. American jouernal of
Clinical Nutrition 34: 2670-2678.

Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF,
Oliver MF. (1991) Risk of angina pectoris and plasma concentrations
of vitamins A, C, and E and carotene. The Lancet
337: 1-5.

Rimm EB, Stampfer MJ, Ascherio AA, Giovannucci E, Colditz
GA, Willett WC. (1993) Vitamin E consumption and the
risk of coronary heart disease in men. New England Journal
of Medicine 328: 1450-1449.

Rivers JM. (1975) Oral contraceptives and ascorbic acid. American
Journal of Clinical Nutrition 28: 550-554.

Rizzon P, Biasco G, Di Biase M, Boscia F, Rizzo U, Minafra F,
Bortone A, Silprandi N, Procopio A, Bagiella E, Corsi M.
(1989) High doses of L-carnitine in acute myocardial infarction:
metabolic and antiarrhythmic effects. European Heart
Journal 10: 502-508.

Rudolph Willi. (1939) Vitamin C und Ern=E4hrung. Enke Verlag
Stuttgart.

Salonen JT, Salonen R, Ihanainen M, Parviainen M, Sepp=E4nen
R, Sepp=E4nen K, Rauramaa R. (1987) Vitamin C deficiency
and low linolenate intake associated with elevated blood
pressure: The Kuopio Ischemic Heart Disease Risk Factor
Study. Journal of Hypertension 5 (Supplement 5): S521-
S524.

Salonen JT, Salonen R, Sepp=E4neen K, Rinta-Kiikka S, Kuukka
M, Korpela H, Alfthan G, Kantola M, Schalch W. (1991)
Effects of Antioxidanz supplementation on platelet function:
a randomized pair-matched, placebo-controlled,
double-blind trial in men with low antioxidant status. Ame-rican
Journal of Clinical Nutrition 53: 1222-1229.

Sauberlich HE, Machlin LJ (Hrsg.). (1992) Beyond deficiency:
new views on the function and health effects of vitamins.
Annals of the New York Academy of Sciences 669.

Smith HA, Jones TC, Hrsg. (1958) Veterinary Pathology.
Sokoloff B, Hori M, Saelhof CC, Wrzolek T, Imai T. (1966)

Aging, atherosclerosis and ascorbic acid metabolism. Journal
of the American Gerontology Society 14: 1239-1260.

Som S, Basu S, Mukherjee D, Deb S, Choudhury PR, Mukherjee
S, Chatterjee SN, Chatterjee IB. (1981) Ascorbic acid
metabolism in diabetes mellitus. Metabolism 30: 572-577.
Spittle CR. (1971) Atherosclerosis and vitamin C. Lancet ii,
1280-1281.

Stankova L, Riddle M, Larned J, Burry K, Menashe D, Hart J,
Bigley R. (1984) Plasma ascorbate concentrations and
blood cell dehydroascorbate transport in patients with diabetes
mellitus. Metabolism 33: 347-353.

Stepp W, Schroeder H, Altenburger E. (1935) Vitamin C und
Blutzucker. Klinische Wochenschrift 14 [26]: 933-934.
Stryer L. (1988) Biochemistry. 3rd edition. W.H. Freeman and
Company New York.

Tarry WC. (1994) L-arginine improves endothelium-dependent
vasorelaxation and reduces intimal hyperplasia after baloon
angioplasty. Arteriosclerosis and Thrombosis 14: 938-943.

Teo KK, Salim Y. (1993) Role of magnesium in reducing morta-lity
in acute myocardial infarction: A review of the evi-dence.
Drugs 46[3}: 347-359.

Thomsen JH, Shug AL, Yap VU et al. (1979) Improved pacing
tolerance of the ischemic human myocardium after administration
of carnitine. American Journal of Cardiology 43:
300-306.

Turlapaty PDMV, Altura BM. (1980) Magnesium deficiency
produces spasms of coronary arteries: relationship to etiology
of sudden death ischemic heart disease. Science 208:
198-200.

Virchow R. (1859) Cellularpathologie. Verlag von August Hirschwald,
Berlin.

Widman L et al. (1993) The dose-dependent reduction in
blood pressure through administration of magnesium:
double-blind placebo controlled cross-over study. American
Journal of Hypertension 6: 41-45.

Willis GC, Light AW, Gow WS. (1954) Serial arteriography in
atherosclerosis. Canadian Medical Association Journal 71:
562-568.

Zenker G, Koeltringer P, Bone G, Kiederkorn K, Pfeiffer K, J=FCrgens
G. (1986) Lipoprotein(a) as a Strong Indicator for Car-diovascular
Disease. Stroke 17: 942-945.

Source: ISBN 90-76332-01-0